Cytokeratin 15 is a novel and independent predictor of poor outcome in luminal B HER2-negative breast carcinomas. Lee DHY, Tsang JY, Li JJX, Lau SL, et al. Pathology 2024;56:834-841.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Lee DHY, Tsang JY, Li JJX, Lau SL, et al. Cytokeratin 15 is a novel and independent predictor of poor outcome in luminal B HER2-negative breast carcinomas. Pathology 2024;56:834-841.
PMID: 38909003